DIA
OXFD

Denver Investment Advisors’s Oxford Immunotec Global PLC Ordinary Shares OXFD Stock Holding History

Denver Investment Advisors’s Portfolio OXFD Stock Details OXFD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-30,880
Closed -$478K – 484
2017
Q1 		$478K Buy
30,880
+9,949
+48% +$142K 0.02% 333
2016
Q4 		$313K Buy
+20,931
New +$294K 0.01% 405

Other funds holding OXFD

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PC
Polar Capital London, United Kingdom $13.5B AUM 55.9% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
Axa
Axa Paris, France $256M AUM 25.01% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Denver Investment Advisors's OXFD Position: Q2 2017 in Review

Denver Investment Advisors sold out of Oxford Immunotec Global PLC Ordinary Shares (OXFD) in Q2 2017, closing a stake of 30,880 shares — an estimated $478K sold.

Denver Investment Advisors first reported a position in OXFD in Q4 2016 and held it in 2 quarters. The position peaked at $478K in Q1 2017. 75 funds tracked by Wall St. Rank hold OXFD as of Q2 2017.

  • Denver Investment Advisors reported no remaining Oxford Immunotec Global PLC Ordinary Shares position as of Q2 2017 after selling out during the quarter.
  • Denver Investment Advisors sold 30,880 Oxford Immunotec Global PLC Ordinary Shares shares in Q2 2017, an estimated $478K.
  • Denver Investment Advisors first reported a position in Oxford Immunotec Global PLC Ordinary Shares in Q4 2016 and held it in 2 quarters.
  • Denver Investment Advisors's Oxford Immunotec Global PLC Ordinary Shares position peaked at $478K in Q1 2017.
  • 75 funds tracked by Wall St. Rank held Oxford Immunotec Global PLC Ordinary Shares as of Q2 2017.

Based on Denver Investment Advisors's 13F filing for Q2 2017, filed 3 Aug 2017.